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LETTER
NOTES & COMMENTSReply to: ‘‘Commentary on ‘A new
drug with a nasty bite: A case of
krokodil-induced skin necrosis in
an intravenous drug user’’’To the Editor: I thank the authors for their reply to our
article. Levamisole, an adulterant most commonly
found in cocaine, can be associated with skin
vasculitis resulting in ulcerating lesions.1,2 The most
common cutaneous findings are characteristic pur-
puric lesions, including retiform purpura or palpable
purpura, which often occur in conjunction with
leukocytoclastic vasculitis. These lesions favor acral
surfaces such as the helical rim or fingertips and are
often antineutrophil cytoplasmic antibody posi-
tive.1,2 On the contrary, large ulcerations on the
forearms would be an unusual presentation for
levamisole toxicity, especially in the absence of
more classic findings as noted above. In cases such
as these, physical examination is important, and
cutaneous findings must be emphasized. The patient
only had involvement where she directly injected the
substance, another finding that is unusual for levam-
isole, which often affects areas distal to areas of
injection owing to systemic activity without antineu-
trophil cytoplasmic antibody positivity. Finally, the
patient voluntarily reported purchasing krokodil
immediately before the ulcerations occurred. I
caution against the author’s sentiment of completely
excluding patient history, especially when clinical
findings support the history provided. We believeª 2016 by the American Academy of Dermatology, Inc. Published
by Elsevier, Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
424 SEPTEMBER 2016that doctors should continue to exercise vigilance
and keep krokodil on their differential of possibilities
in cases of large ulcerations in patients with a history
of intravenous drug use.
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